At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 212 enrolled
Drug / intervention
Terconazole +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
In Brief
A Phase 3 clinical trial evaluating Terconazole and Placebo for Vaginal Infection. Completed, enrolled 212 participants across 41 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of terconazole gel in the treatment of vaginal infections
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVaginal Infection
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
First PostedDec 2014
Enrollment StartJun 2015
Primary CompletionJun 2017
TodayJul 2026
First PostedDec 4, 2014
Enrollment StartJun 1, 2015
Primary CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 11.6 years ago
Interventions
Terconazoledrug
Placebodrug